Ampullary cancer ESPAC-3 (v2) trial: A multicenter, international, open-label, randomized controlled phase III trial of adjuvant chemotherapy versus observation in patients with adenocarcinoma of the ampulla of vater

被引：0
|
作者：
Neoptolemos, J. P.
Moore, M. J.
Cox, T. F.
Valle, J. W.
Palmer, D. H.
Mcdonald, A.
Carter, R.
Tebbutt, N. C.
Dervenis, C.
Smith, D.
Glimelius, B.
Coxon, F. Y.
Lacaine, F.
Middleton, M. R.
Ghaneh, P.
Bassi, C.
Halloran, C.
Olah, A.
Rawcliffe, C. L.
Buechler, M. W.
机构：
[1] Univ Liverpool, Liverpool L69 3BX, Merseyside, England
[2] Princess Margaret Hosp, Dept Med Oncol, Toronto, ON M4X 1K9, Canada
[3] Univ Toronto, Toronto, ON, Canada
[4] Christie NHS Fdn Trust, Dept Med Oncol, Manchester, Lancs, England
[5] CRUK Inst Canc Studies, Birmingham, W Midlands, England
[6] Beatson West Scotland Canc Ctr, Glasgow, Lanark, Scotland
[7] Glasgow Royal Infirm, Glasgow G4 0SF, Lanark, Scotland
[8] Austin Hosp, Ludwig Oncol Unit, Heidelberg, Vic 3084, Australia
[9] Aiga Olga Hosp, Athens, Greece
[10] Clatterbridge Ctr Oncol NHS Fdn Trust, Wirral, Merseyside, England
[11] Akad Univ Hosp, Uppsala, Sweden
[12] Northern Ctr Canc Care, Newcastle Upon Tyne, Tyne & Wear, England
[13] Hosp Tenon, Paris, France
[14] Oxford Radcliffe Hosp, Oxford, England
[15] Univ Verona, Dept Surg, I-37100 Verona, Italy
[16] Petz Aladar Cty Hosp, Gyor, Hungary
[17] Heidelberg Univ, Heidelberg, Germany
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2011年 / 29卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
LBA4006
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Ampullary cancer ESPAC-3 (v2) trial: A multicenter, international, open-label, randomized controlled phase III trial of adjuvant chemotherapy versus observation in patients with adenocarcinoma of the ampulla of vater
    Neoptolemos, J. P.
    Moore, M. J.
    Cox, T. F.
    Valle, J. W.
    Palmer, D. H.
    Mcdonald, A.
    Carter, R.
    Tebbutt, N. C.
    Dervenis, C.
    Smith, D.
    Glimelius, B.
    Coxon, F. Y.
    Lacaine, F.
    Middleton, M. R.
    Ghaneh, P.
    Bassi, C.
    Halloran, C.
    Olah, A.
    Rawcliffe, C. L.
    Buechler, M. W.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [2] Periampullary Cancer ESPAC-3(v2) trial: a Randomised Controlled Phase III Trial of Adjuvant Chemotherapy Versus Observation in Patients With Periampullary Adenocarcinomas of the Head of the Pancreas
    Neoptolemos, J.
    Moore, M.
    Cox, T.
    Valle, J.
    Palmer, D.
    Mcdonald, A.
    Carter, R.
    Tebbutt, N.
    Dervenis, C.
    Smith, D.
    Glimelius, B.
    Coxon, F.
    Lacaine, F.
    Middleton, M.
    Ghaneh, P.
    Bassi, C.
    Halloran, C.
    Olah, A.
    Rawcliffe, C.
    Buechler, M.
    [J]. PANCREAS, 2011, 40 (08) : 1343 - 1343
  • [3] ESPAC-3(v2): A multicenter, international, open-label, randomized controlled phase III trial of adjuvant 5-fluorouracil/folinic acid (5-FU/FA) versus gemcitabine (GEM) in patients with resected pancreatic ductal adenocarcinoma
    Neoptolemos, J.
    Buechler, M.
    Stocken, D. D.
    Ghaneh, P.
    Smith, D.
    Bassi, C.
    Moore, M.
    Cunningham, D.
    Dervenis, C.
    Goldstein, D.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [4] ESPAC-3(v2): A multicenter, international, open-label, randomized, controlled phase III trial of adjuvant 5-fluorouracil/folinic acid (5-FU/FA) versus gemcitabine (GEM) in patients with resected pancreatic ductal adenocarcinoma
    Neoptolemos, J.
    Buechler, M.
    Stocken, D. D.
    Ghaneh, P.
    Smith, D.
    Bassi, C.
    Moore, M.
    Cunningham, D.
    Dervenis, C.
    Goldstein, D.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (18)
  • [5] Early versus conventional adjuvant chemotherapy in stage III colon cancer: A multicenter, randomized, open-label, phase 3 trial
    Park, Soo Yeun
    Kim, So Hyun
    Lee, Kyung Ha
    Song, Seung Ho
    Kim, Hye Jin
    Kim, Jong Gwang
    Kang, Byung Woog
    Baek, Seong Kyu
    Jeong, Woon Kyung
    Bae, Sung Uk
    Lee, In Kyu
    Lee, Yoon Suk
    Son, Gyung Mo
    Bae, Ki Beom
    Kim, Ji Yeon
    Park, Jun Seok
    Choi, Gyu-Seog
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [6] ESPAC-4: A multicenter, international, open-label randomized controlled phase III trial of adjuvant combination chemotherapy of gemcitabine (GEM) and capecitabine (CAP) versus monotherapy gemcitabine in patients with resected pancreatic ductal adenocarcinoma.
    Neoptolemos, John P.
    Palmer, Dan
    Ghaneh, Paula
    Valle, Juan W.
    Cunningham, David
    Wadsley, Jonathan
    Meyer, Tim
    Anthoney, Alan
    Glimelius, Bengt
    Falk, Stephen
    Segersvard, Ralf
    Izbicki, Jakob R.
    Middleton, Gary William
    Ross, Paul J.
    Wasan, Harpreet
    Mcdonald, Alec
    Crosby, Tom David Lewis
    Psarelli, Eftychia Eirini
    Hammel, Pascal
    Buchler, Markus W.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (18)
  • [7] Hybrid minimally invasive versus open oesophagectomy for patients with oesophageal cancer: A multicenter, open-label, randomized phase III controlled trial, the MIRO trial
    Mariette, Christophe
    Meunier, Bernard
    Pezet, Denis
    Dalban, Cecile
    Collet, Denis
    Thomas, Pascal-Alexandre
    Brigand, Cecile
    Perniceni, Thierry
    Carrere, Nicolas
    Bonnetain, Franck
    Piessen, Guillaume
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (03)
  • [8] Radioembolization With Chemotherapy for Colorectal Liver Metastases: A Randomized, Open-Label, International, Multicenter, Phase III Trial
    Mulcahy, Mary F.
    Mahvash, Armeen
    Pracht, Marc
    Montazeri, Amir H.
    Bandula, Steve
    Martin, Robert C. G., II
    Herrmann, Ken
    Brown, Ewan
    Zuckerman, Darryl
    Wilson, Gregory
    Kim, Tae-You
    Weaver, Andrew
    Ross, Paul
    Harris, William P.
    Graham, Janet
    Mills, Jamie
    Yubero Esteban, Alfonso
    Johnson, Matthew S.
    Sofocleous, Constantinos T.
    Padia, Siddharth A.
    Lewandowski, Robert J.
    Garin, Etienne
    Sinclair, Philip
    Salem, Riad
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (35) : 3897 - +
  • [9] ESPAC-4: A multicenter, international, open-label randomized controlled phase III trial of adjuvant combination chemotherapy of gemcitabine (GEM) and capecitabine (CAP) versus monotherapy gemcitabine in patients with resected pancreatic ductal adenocarcinoma: Five year follow-up.
    Neoptolemos, John P.
    Palmer, Daniel H.
    Ghaneh, Paula
    Valle, Juan W.
    Cunningham, David
    Wadsley, Jonathan
    Meyer, Tim
    Anthoney, Alan
    Glimelius, Bengt
    Falk, Stephen
    Segersvard, Ralf
    Middleton, Gary William
    Ross, Paul J.
    Wasan, Harpreet Singh
    McDonald, Alec
    Crosby, Tom David Lewis
    Psarelli, Eftychia Eirini
    Hammel, Pascal
    Hackert, Thilo
    Buchler, Markus W.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [10] Effect of Adjuvant Chemotherapy With Fluorouracil Plus Folinic Acid or Gemcitabine vs Observation on Survival in Patients With Resected Periampullary Adenocarcinoma The ESPAC-3 Periampullary Cancer Randomized Trial
    Neoptolemos, John P.
    Moore, Malcolm J.
    Cox, Trevor F.
    Valle, Juan W.
    Palmer, Daniel H.
    McDonald, Alexander C.
    Carter, Ross
    Tebbutt, Niall C.
    Dervenis, Christos
    Smith, David
    Glimelius, Bengt
    Charnley, Richard M.
    Lacaine, Francois
    Scarfe, Andrew G.
    Middleton, Mark R.
    Anthoney, Alan
    Ghaneh, Paula
    Halloran, Christopher M.
    Lerch, Markus M.
    Olah, Attila
    Rawcliffe, Charlotte L.
    Verbeke, Caroline S.
    Campbell, Fiona
    Buechler, Markus W.
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2012, 308 (02): : 147 - 156
12345